Scholarlink

Background <p>Metabolic dysfunction-associated fatty liver disease (MAFLD), characterized by abnormal accumulation of triglycerides (TG) and cholesterol in hepatocytes, is a globally prevalent chronic liver disease with a rising incidence that poses a severe threat to human health. In the absence of effective targeted drugs and long-term prognostic interventions for MAFLD, aerobic exercise, as a safe and accessible non-pharmacological strategy, is widely recognized to slow MAFLD progression. However, a systematic summary of its mechanisms in ameliorating MAFLD remains insufficient.</p> Main body <p>This review integrates recent high-quality PubMed studies and classic models (e.g., high-fat diet-induced C57BL/6J mice, HepG2 cells) to analyze aerobic exercise’s therapeutic effects on MAFLD and underlying molecular mechanisms. Aerobic exercise regulates MAFLD via a multi-dimensional network. SESN family signaling regulates hepatic lipid metabolism, improves insulin resistance, enhances antioxidant capacity, and promotes lipophagy. miRNA-mediated regulation modulates lipogenic gene expression, insulin signaling, and fatty acid oxidation via exercise-induced changes in key miRNAs and their upstream regulators or downstream targets. AMPK-centered energy metabolism orchestrates fatty acid β-oxidation promotion and de-novo lipogenesis suppression through its related pathways. Other key pathways include inhibiting lipogenesis via exercise-induced IL-6, blocking hepatic inflammation through brown adipose-derived Nrg4, optimizing lipid droplet-mitochondria interaction by regulating PLIN5 and Mfn-2, and suppressing ferroptosis via activating antioxidant pathways. Notably, mechanisms initially validated in non-alcoholic fatty liver disease (NAFLD) are equally applicable to MAFLD, as both are characterized by core metabolic dysfunction.</p> Conclusion <p>Aerobic exercise alleviates MAFLD progression by orchestrating a complex regulatory network involving energy metabolism, stress response, post-transcriptional modification, and inter-organ crosstalk. This review clarifies the key molecular targets and signaling pathways underlying aerobic exercise’s therapeutic effects, providing a theoretical basis for exploring potential targeted interventions and guiding future drug development for MAFLD.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Unlocking the benefits of aerobic exercise for MAFLD: a comprehensive mechanistic analysis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月9日

查看全文
  • Wenting Zhang,
  • Yu Hu,
  • Fang Zou,
  • Lianlei Ding,
  • Meixiu Jiang

摘要

Background

Metabolic dysfunction-associated fatty liver disease (MAFLD), characterized by abnormal accumulation of triglycerides (TG) and cholesterol in hepatocytes, is a globally prevalent chronic liver disease with a rising incidence that poses a severe threat to human health. In the absence of effective targeted drugs and long-term prognostic interventions for MAFLD, aerobic exercise, as a safe and accessible non-pharmacological strategy, is widely recognized to slow MAFLD progression. However, a systematic summary of its mechanisms in ameliorating MAFLD remains insufficient.

Main body

This review integrates recent high-quality PubMed studies and classic models (e.g., high-fat diet-induced C57BL/6J mice, HepG2 cells) to analyze aerobic exercise’s therapeutic effects on MAFLD and underlying molecular mechanisms. Aerobic exercise regulates MAFLD via a multi-dimensional network. SESN family signaling regulates hepatic lipid metabolism, improves insulin resistance, enhances antioxidant capacity, and promotes lipophagy. miRNA-mediated regulation modulates lipogenic gene expression, insulin signaling, and fatty acid oxidation via exercise-induced changes in key miRNAs and their upstream regulators or downstream targets. AMPK-centered energy metabolism orchestrates fatty acid β-oxidation promotion and de-novo lipogenesis suppression through its related pathways. Other key pathways include inhibiting lipogenesis via exercise-induced IL-6, blocking hepatic inflammation through brown adipose-derived Nrg4, optimizing lipid droplet-mitochondria interaction by regulating PLIN5 and Mfn-2, and suppressing ferroptosis via activating antioxidant pathways. Notably, mechanisms initially validated in non-alcoholic fatty liver disease (NAFLD) are equally applicable to MAFLD, as both are characterized by core metabolic dysfunction.

Conclusion

Aerobic exercise alleviates MAFLD progression by orchestrating a complex regulatory network involving energy metabolism, stress response, post-transcriptional modification, and inter-organ crosstalk. This review clarifies the key molecular targets and signaling pathways underlying aerobic exercise’s therapeutic effects, providing a theoretical basis for exploring potential targeted interventions and guiding future drug development for MAFLD.